Review
Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis
Affiliations
- PMID: 12082202
Item in Clipboard
Review
Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis
J Invasive Cardiol.
2002 Jul.
Abstract
The only gamma emitter used in clinical trials for in-stent restenosis is 192Iridium (192Ir). The efficacy of intracoronary gamma radiation therapy in reducing clinical and angiographic restenosis in patients with in-stent restenosis has been established. This review is intended to give an overview of the clinical trials utilizing gamma vascular brachytherapy in patients with in-stent restenosis and give insight into the future of intracoronary radiation therapy.
Similar articles
-
Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.Am Heart J. 2003 Nov;146(5):775-86. doi: 10.1016/S0002-8703(03)00389-2. Am Heart J. 2003. PMID: 14597925 Review.
-
Multiple ulcerations in plaque behind stent struts resulting in late stent malapposition after gamma brachytherapy for in-stent restenosis.J Invasive Cardiol. 2003 Sep;15(9):530-2. J Invasive Cardiol. 2003. PMID: 12947216
-
[Brachytherapy after coronary interventions: current state and future perspectives].Z Kardiol. 2003 Jan;92(1):1-15. doi: 10.1007/s00392-003-0843-5. Z Kardiol. 2003. PMID: 12545296 Review. German.
-
Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience.Ital Heart J. 2003 Mar;4(3):199-204. Ital Heart J. 2003. PMID: 12784747
-
A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stenting.J Invasive Cardiol. 2006 Apr;18(4):169-73. J Invasive Cardiol. 2006. PMID: 16732060 Clinical Trial.